Simulating cancer growth with multiscale agent-based modeling

Seminars in Cancer Biology

Volumn 30, Issue , 2015, Pages 70-78

  Wang, Zhihui ^a   Butner, Joseph D ^b   Kerketta, Romica ^a   Cristini, Vittorio ^a,b,c   Deisboeck, Thomas S ^d,e  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b University of New Mexico   (United States)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^d ThinkMotu LLC   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Drug discovery; Mathematical modeling; Signaling pathway; Translational research; Tumor growth and invasion

Indexed keywords

OXYGEN;

ADAPTATION; ANGIOGENESIS; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER STEM CELL; CANCER SURGERY; CELL METABOLISM; CELL POPULATION; EXTRACELLULAR MATRIX; GENE MUTATION; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; MATHEMATICAL MODEL; MULTISCALE AGENT BASED MODELING; NUTRIENT; PHENOTYPE; REVIEW; SIGNAL TRANSDUCTION; SIMULATION; TRANSLATIONAL RESEARCH; TREATMENT RESPONSE; TUMOR INVASION; TUMOR MICROENVIRONMENT; BIOLOGICAL MODEL; COMPUTER SIMULATION; NEOPLASM; PATHOLOGY; THEORETICAL MODEL;

COMPUTER SIMULATION; HUMANS; MODELS, BIOLOGICAL; MODELS, THEORETICAL; NEOPLASMS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84919647463     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2014.04.001     Document Type: Review

References (92)

1. Knudson A.G. Cancer genetics. Am J Med Genet 2002, 111:96-102.
2. Werfel J., Krause S., Bischof A.G., Mannix R.J., Tobin H., Bar-Yam Y., et al. How changes in extracellular matrix mechanics and gene expression variability might combine to drive cancer progression. PLoS ONE 2013, 8:0076122.
3. Edelman L.B., Eddy J.A., Price N.D. In silico models of cancer. Wiley Interdiscip Rev Syst Biol Med 2010, 2:438-459.
4. Deisboeck T.S., Wang Z., Macklin P., Cristini V. Multiscale cancer modeling. Annu Rev Biomed Eng 2011, 13:127-155.
5. Lowengrub J.S., Frieboes H.B., Jin F., Chuang Y.L., Li X., Macklin P., et al. Nonlinear modelling of cancer: bridging the gap between cells and tumours. Nonlinearity 2010, 23:R1-R91.
6. Tracqui P. Biophysical models of tumour growth. Rep Prog Phys 2009, 72:056701.
7. Rejniak K.A., Anderson A.R. Hybrid models of tumor growth. Wiley Interdiscip Rev Syst Biol Med 2011, 3:115-125.
8. Schnell S., Grima R., Maini P.K. Multiscale modeling in biology - new insights into cancer illustrate how mathematical tools are enhancing the understanding of life from the smallest scale to the grandest. Am Sci 2007, 95:134-142.
9. Johnson D., McKeever S., Stamatakos G., Dionysiou D., Graf N., Sakkalis V., et al. Dealing with diversity in computational cancer modeling. Cancer Inform 2013, 12:115-124.
10. Byrne H., Drasdo D. Individual-based and continuum models of growing cell populations: a comparison. J Math Biol 2009, 58:657-687.
11. Anderson A.R., Chaplain M.A., Rejniak K.A. Single-cell-based models in biology and medicine 2007, Springer, Basel, Switzerland.
12. An G., Mi Q., Dutta-Moscato J., Vodovotz Y. Agent-based models in translational systems biology. Wiley Interdiscip Rev Syst Biol Med 2009, 1:159-171.
13. Railsback S.F., Lytinen S.L., Jackson S.K. Agent-based simulation platforms: review and development recommendations. Simulation 2006, 82:609-623.
14. Walker D.C., Southgate J. The virtual cell - a candidate co-ordinator for 'middle-out' modelling of biological systems. Brief Bioinform 2009, 10:450-461.
15. Di Ventura B., Lemerle C., Michalodimitrakis K., Serrano L. From in vivo to in silico biology and back. Nature 2006, 443:527-533.
16. Bissell M.J., Radisky D. Putting tumours in context. Nat Rev Cancer 2001, 1:46-54.
17. Gatenby R.A., Silva A.S., Gillies R.J., Frieden B.R. Adaptive therapy. Cancer Res 2009, 69:4894-4903.
18. Cristini V., Lowengrub J. Multiscale modeling of cancer: an integrated experimental and mathematical modeling approach 2010, Cambridge University Press, Cambridge, UK.
19. Dattoli G., Guiot C., Delsanto P.P., Ottaviani P.L., Pagnutti S., Deisboeck T.S. Cancer metabolism and the dynamics of metastasis. J Theor Biol 2009, 256:305-310.
20. Wang Z., Deisboeck T.S. Computational modeling of brain tumors: discrete, continuum or hybrid. Sci Model Simul 2008, 15:381-393.
21. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
22. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
23. Sanga S., Frieboes H.B., Zheng X., Gatenby R., Bearer E.L., Cristini V. Predictive oncology: a review of multidisciplinary, multiscale in silico modeling linking phenotype, morphology and growth. NeuroImage 2007, 37(Suppl. 1):S120-S134.
24. Zhang L., Jiang B., Wu Y., Strouthos C., Sun P.Z., Su J., et al. Developing a multiscale, multi-resolution agent-based brain tumor model by graphics processing units. Theor Biol Med Model 2011, 8:1742-4682.
25. Wang Z., Zhang L., Sagotsky J., Deisboeck T.S. Simulating non-small cell lung cancer with a multiscale agent-based model. Theor Biol Med Model 2007, 4:50.
26. Wang Z., Birch C.M., Sagotsky J., Deisboeck T.S. Cross-scale, cross-pathway evaluation using an agent-based non-small cell lung cancer model. Bioinformatics 2009, 25:2389-2396.
27. Wang Z., Birch C.M., Deisboeck T.S. Cross-scale sensitivity analysis of a non-small cell lung cancer model: linking molecular signaling properties to cellular behavior. BioSystems 2008, 92:249-258.
28. Wang Z., Bordas V., Deisboeck T.S. Identification of critical molecular components in a multiscale cancer model based on the integration of Monte Carlo, resampling, and ANOVA. Front Physiol 2011, 2:35.
29. Wang Z., Bordas V., Sagotsky J., Deisboeck T.S. Identifying therapeutic targets in a combined EGFR-TGFbetaR signalling cascade using a multiscale agent-based cancer model. Math Med Biol 2012, 29:95-108.
30. Wang Z., Deisboeck T.S. Mathematical modeling in cancer drug discovery. Drug Discov Today 2014, 19:145-150.
31. Wang Z., Deisboeck T.S., Cristini V. Development of a sampling-based global sensitivity analysis workflow for multiscale computational cancer models. IET Syst Biol 2014, [in press]. 10.1049/iet-syb.2013.0026.
32. Sun X., Zhang L., Tan H., Bao J., Strouthos C., Zhou X. Multi-scale agent-based brain cancer modeling and prediction of TKI treatment response: incorporating EGFR signaling pathway and angiogenesis. BMC Bioinform 2012, 13:1471-2105.
33. Zu X.L., Guppy M. Cancer metabolism: facts, fantasy, and fiction. Biochem Biophys Res Commun 2004, 313:459-465.
34. Pelicano H., Martin D.S., Xu R.H., Huang P. Glycolysis inhibition for anticancer treatment. Oncogene 2006, 25:4633-4646.
35. Estrella V., Chen T., Lloyd M., Wojtkowiak J., Cornnell H.H., Ibrahim-Hashim A., et al. Acidity generated by the tumor microenvironment drives local invasion. Cancer Res 2013, 73:1524-1535.
36. Maini P.K., Gatenby R.A., Smallbone K. Modelling aspects of tumour metabolism. Proceedings of the International Congress of Mathematics 2010, R. Bhatia (Ed.).
37. Smallbone K., Gatenby R.A., Gillies R.J., Maini P.K., Gavaghan D.J. Metabolic changes during carcinogenesis: potential impact on invasiveness. J Theor Biol 2007, 244:703-713.
38. Gatenby R.A., Smallbone K., Maini P.K., Rose F., Averill J., Nagle R.B., et al. Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer. Br J Cancer 2007, 97:646-653.
39. Silva A.S., Gatenby R.A. A theoretical quantitative model for evolution of cancer chemotherapy resistance. Biol Direct 2010, 5:25.
40. Gerlee P., Anderson A.R. A hybrid cellular automaton model of clonal evolution in cancer: the emergence of the glycolytic phenotype. J Theor Biol 2008, 250:705-722.
41. Giese A., Loo M.A., Tran N., Haskett D., Coons S.W., Berens M.E. Dichotomy of astrocytoma migration and proliferation. Int J Cancer 1996, 67:275-282.
42. Brown J.M., Wilson W.R. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 2004, 4:437-447.
43. Gerlee P., Anderson A.R. An evolutionary hybrid cellular automaton model of solid tumour growth. J Theor Biol 2007, 246:583-603.
44. Gerlee P., Anderson A.R. Evolution of cell motility in an individual-based model of tumour growth. J Theor Biol 2009, 259:67-83.
45. Araujo A., Baum B., Bentley P. The role of chromosome missegregation in cancer development: a theoretical approach using agent-based modelling. PLoS ONE 2013, 8:0072206.
46. Zetter B.R. Angiogenesis and tumor metastasis. Annu Rev Med 1998, 49:407-424.
47. Folkman J., Klagsbrun M. Angiogenic factors. Science 1987, 235:442-447.
48. Anderson A.R., Chaplain M.A. Continuous and discrete mathematical models of tumor-induced angiogenesis. Bull Math Biol 1998, 60:857-899.
49. Olsen M.M., Siegelmann H.T. Multiscale agent-based model of tumor angiogenesis. Proc Comput Sci 2013, 18:1016-1025.
50. Frieboes H.B., Jin F., Chuang Y.L., Wise S.M., Lowengrub J.S., Cristini V. Three-dimensional multispecies nonlinear tumor growth-II: tumor invasion and angiogenesis. J Theor Biol 2010, 264:1254-1278.
51. Macklin P., McDougall S., Anderson A.R., Chaplain M.A., Cristini V., Lowengrub J. Multiscale modelling and nonlinear simulation of vascular tumour growth. J Math Biol 2009, 58:765-798.
52. Wu M., Frieboes H.B., McDougall S.R., Chaplain M.A., Cristini V., Lowengrub J. The effect of interstitial pressure on tumor growth: coupling with the blood and lymphatic vascular systems. J Theor Biol 2013, 320:131-151.
53. Alexandrova A.Y. Evolution of cell interactions with extracellular matrix during carcinogenesis. Biochemistry (Moscow) 2008, 73:733-741.
54. Anderson A.R. A hybrid mathematical model of solid tumour invasion: the importance of cell adhesion. Math Med Biol 2005, 22:163-186.
55. Macklin P., Edgerton M.E., Thompson A.M., Cristini V. Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): from microscopic measurements to macroscopic predictions of clinical progression. J Theor Biol 2012, 301:122-140.
56. Hyun A.Z., Macklin P. Improved patient-specific calibration for agent-based cancer modeling. J Theor Biol 2013, 317:422-424.
57. Chapa J., Bourgo R.J., Greene G.L., Kulkarni S., An G. Examining the pathogenesis of breast cancer using a novel agent-based model of mammary ductal epithelium dynamics. PLoS ONE 2013, 8(5):e64091.
58. Anderson A.R., Weaver A.M., Cummings P.T., Quaranta V. Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell 2006, 127:905-915.
59. Sethi N., Kang Y. Unravelling the complexity of metastasis - molecular understanding and targeted therapies. Nat Rev Cancer 2011, 11:735-748.
60. Wynn M.L., Kulesa P.M., Schnell S. Computational modelling of cell chain migration reveals mechanisms that sustain follow-the-leader behaviour. J R Soc Interface 2012, 9:1576-1588.
61. Deisboeck T.S., Couzin I.D. Collective behavior in cancer cell populations. BioEssays 2009, 31:190-197.
62. Cheung K.J., Gabrielson E., Werb Z., Ewald A.J. Collective invasion in breast cancer requires a conserved basal epithelial program. Cell 2013, 155:1639-1651.
63. Soltysova A., Altanerova V., Altaner C. Cancer stem cells. Neoplasma 2005, 52:435.
64. Siddique H.R., Saleem M. Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences. Stem Cells 2012, 30:372-378.
65. Bagnato A., Rosanò L. Understanding and overcoming chemoresistance in ovarian cancer: emerging role of the endothelin axis. Curr Oncol 2012, 19:36.
66. Biava P.M., Basevi M., Biggiero L., Borgonovo A., Borgonovo E., Burigana F. Cancer cell reprogramming: stem cell differentiation stage factors and an agent based model to optimize cancer treatment. Curr Pharm Biotechnol 2011, 12:231-242.
67. Enderling H., Anderson A.R., Chaplain M.A., Beheshti A., Hlatky L., Hahnfeldt P. Paradoxical dependencies of tumor dormancy and progression on basic cell kinetics. Cancer Res 2009, 69:8814-8821.
68. Enderling H., Hlatky L., Hahnfeldt P. Migration rules: tumours are conglomerates of self-metastases. Br J Cancer 2009, 100:1917-1925.
69. Enderling H., Hlatky L., Hahnfeldt P. The promoting role of a tumour-secreted chemorepellent in self-metastatic tumour progression. Math Med Biol 2012, 29:21-29.
70. Hale N.A., Yang Y., Rajagopalan P. Cell migration at the interface of a dual chemical-mechanical gradient. ACS Appl Mater Interfaces 2010, 2:2317-2324.
71. Enderling H., Chaplain M.A., Anderson A.R., Vaidya J.S. A mathematical model of breast cancer development, local treatment and recurrence. J Theor Biol 2007, 246:245-259.
72. Mukhopadhyay R., Costes S.V., Bazarov A.V., Hines W.C., Barcellos-Hoff M.H., Yaswen P. Promotion of variant human mammary epithelial cell outgrowth by ionizing radiation: an agent-based model supported by in vitro studies. Breast Cancer Res 2010, 12:10.
73. Powathil G.G., Gordon K.E., Hill L.A., Chaplain M.A. Modelling the effects of cell-cycle heterogeneity on the response of a solid tumour to chemotherapy: biological insights from a hybrid multiscale cellular automaton model. J Theor Biol 2012, 308:1-19.
74. Novak B., Tyson J.J. A model for restriction point control of the mammalian cell cycle. J Theor Biol 2004, 230:563-579.
75. Tyson J.J., Novak B. Regulation of the eukaryotic cell cycle: molecular antagonism, hysteresis, and irreversible transitions. J Theor Biol 2001, 210:249-263.
76. Woelke A.L., Murgueitio M.S., Preissner R. Theoretical modeling techniques and their impact on tumor immunology. Clin Dev Immunol 2010, 271794:23.
77. Kim P.S., Lee P.P. Modeling protective anti-tumor immunity via preventative cancer vaccines using a hybrid agent-based and delay differential equation approach. PLoS Comput Biol 2012, 8:e1002742.
78. Pennisi M., Pappalardo F., Palladini A., Nicoletti G., Nanni P., Lollini P.L., et al. Modeling the competition between lung metastases and the immune system using agents. BMC Bioinform 2010, 15:1471-2105.
79. Lollini P.L., Motta S., Pappalardo F. Discovery of cancer vaccination protocols with a genetic algorithm driving an agent based simulator. BMC Bioinform 2006, 7:352.
80. Palazon A., Teijeira A., Martinez-Forero I., Hervas-Stubbs S., Roncal C., Penuelas I., et al. Agonist anti-CD137 mAb act on tumor endothelial cells to enhance recruitment of activated T lymphocytes. Cancer Res 2011, 71:801-811.
81. Pappalardo F., Martinez Forero I., Pennisi M., Palazon A., Melero Motta S. SimB16: modeling induced immune system response against B16-melanoma. PLoS ONE 2011, 6:19.
82. von Eichborn J., Woelke A.L., Castiglione F., Preissner R. VaccImm: simulating peptide vaccination in cancer therapy. BMC Bioinform 2013, 14:1471-2105.
83. Woelke A.L., von Eichborn J., Murgueitio M.S., Worth C.L., Castiglione F., Preissner R. Development of immune-specific interaction potentials and their application in the multi-agent-system VaccImm. PLoS ONE 2011, 6:17.
84. Castiglione F., Toschi F., Bernaschi M., Succi S., Benedetti R., Falini B., et al. Computational modeling of the immune response to tumor antigens. J Theor Biol 2005, 237:390-400.
85. Wang Z., Sagotsky J., Taylor T., Shironoshita P., Deisboeck T.S. Accelerating cancer systems biology research through Semantic Web technology. Wiley Interdiscip Rev Syst Biol Med 2013, 5:135-151.
86. Winslow R.L., Trayanova N., Geman D., Miller M.I. Computational medicine: translating models to clinical care. Sci Transl Med 2012, 4:158rv11.
87. Ren W.Q., WN.F E. Heterogeneous multiscale method for the modeling of complex fluids and micro-fluidics. J Comput Phys 2005, 204:1-26.
88. Kevrekidis I.G., Samaey G. Equation-free multiscale computation: algorithms and applications. Annu Rev Phys Chem 2009, 60:321-344.
89. Archer A.J., Evans R. Dynamical density functional theory and its application to spinodal decomposition. J Chem Phys 2004, 121:4246-4254.
90. Chauviere A., Hatzikirou H., Kevrekidis I.G., Lowengrub J.S., Cristini V. Dynamic density functional theory of solid tumor growth: preliminary models. AIP Adv 2012, 2:11210.
91. Dittmar T., Husemann A., Schewe Y., Nofer J.R., Niggemann B., Zanker K.S., et al. Induction of cancer cell migration by epidermal growth factor is initiated by specific phosphorylation of tyrosine 1248 of c-erbB-2 receptor via EGFR. FASEB J 2002, 16:1823-1825.
92. Santos S.D., Verveer P.J., Bastiaens P.I. Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate. Nat Cell Biol 2007, 9:324-330.